Female Health ROA 2006-2019 | VERU
Current and historical return on assets (ROA) values for Female Health (VERU) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Female Health ROA for the three months ending December 31, 2019 was -24.74%.
| Female Health ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-12-31 | $-0.01B | $0.06B | -24.30% |
| 2019-09-30 | $-0.01B | $0.05B | -22.75% |
| 2019-06-30 | $-0.02B | $0.05B | -33.17% |
| 2019-03-31 | $-0.02B | $0.05B | -43.14% |
| 2018-12-31 | $-0.02B | $0.05B | -41.71% |
| 2018-09-30 | $-0.02B | $0.05B | -45.71% |
| 2018-06-30 | $-0.02B | $0.05B | -38.71% |
| 2018-03-31 | $-0.01B | $0.06B | -25.34% |
| 2017-12-31 | $-0.01B | $0.05B | -21.82% |
| 2017-09-30 | $-0.01B | $0.06B | -15.65% |
| 2017-06-30 | $-0.01B | $0.06B | -11.21% |
| 2017-03-31 | $-0.00B | $0.06B | -8.08% |
| 2016-12-31 | $-0.00B | $0.06B | -4.42% |
| 2016-09-30 | $0.00B | $0.04B | 0.00% |
| 2016-06-30 | $0.00B | $0.04B | 7.64% |
| 2016-03-31 | $0.00B | $0.04B | 7.84% |
| 2015-12-31 | $0.01B | $0.04B | 13.42% |
| 2015-09-30 | $0.01B | $0.04B | 13.99% |
| 2015-06-30 | $0.00B | $0.04B | 8.70% |
| 2015-03-31 | $0.00B | $0.04B | 8.96% |
| 2014-12-31 | $0.00B | $0.03B | 3.05% |
| 2014-09-30 | $0.00B | $0.03B | 3.01% |
| 2014-06-30 | $0.01B | $0.03B | 26.47% |
| 2014-03-31 | $0.01B | $0.03B | 26.67% |
| 2013-12-31 | $0.01B | $0.04B | 35.56% |
| 2013-09-30 | $0.02B | $0.04B | 46.15% |
| 2013-06-30 | $0.02B | $0.03B | 51.20% |
| 2013-03-31 | $0.02B | $0.03B | 61.02% |
| 2012-12-31 | $0.02B | $0.03B | 62.96% |
| 2012-09-30 | $0.02B | $0.03B | 64.65% |
| 2012-06-30 | $0.01B | $0.03B | 59.09% |
| 2012-03-31 | $0.01B | $0.02B | 51.28% |
| 2011-12-31 | $0.01B | $0.02B | 45.07% |
| 2011-09-30 | $0.01B | $0.02B | 29.85% |
| 2011-06-30 | $0.01B | $0.02B | 36.36% |
| 2011-03-31 | $0.01B | $0.02B | 36.92% |
| 2010-12-31 | $0.01B | $0.02B | 49.23% |
| 2010-09-30 | $0.01B | $0.02B | 44.44% |
| 2010-06-30 | $0.00B | $0.01B | 18.75% |
| 2010-03-31 | $0.00B | $0.02B | 24.62% |
| 2009-12-31 | $0.00B | $0.02B | 25.81% |
| 2009-09-30 | $0.01B | $0.02B | 47.46% |
| 2009-06-30 | $0.01B | $0.02B | 51.85% |
| 2009-03-31 | $0.01B | $0.01B | 53.85% |
| 2008-12-31 | $0.01B | $0.01B | 46.15% |
| 2008-09-30 | $0.01B | $0.01B | 37.74% |
| 2008-06-30 | $0.00B | $0.01B | 32.00% |
| 2008-03-31 | $0.00B | $0.01B | 26.09% |
| 2007-12-31 | $0.00B | $0.01B | 19.05% |
| 2007-09-30 | $0.00B | $0.01B | 10.81% |
| 2007-06-30 | $0.00B | $0.01B | 0.00% |
| 2007-03-31 | $0.00B | $0.01B | 0.00% |
| 2006-12-31 | $0.00B | $0.01B | 0.00% |
| 2006-09-30 | $0.00B | $0.01B | 0.00% |
| 2006-06-30 | $0.00B | $0.01B | 0.00% |
| 2006-03-31 | $0.00B | $0.01B | 0.00% |
| 2005-12-31 | $0.00B | $0.01B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.276B | $0.032B |
| Veru Inc. engages in the development, manufacture and marketing of consumer health care products. It focuses on producing FC2 female condom which provides dual protection against unintended pregnancy and sexually transmitted infections. Veru Inc., formerly known as The Female Health Company, is headquartered in Miami, FL. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $158.029B | 27.58 |
| Medtronic (MDT) | Ireland | $152.495B | 20.50 |
| Stryker (SYK) | United States | $84.317B | 27.25 |
| Boston Scientific (BSX) | United States | $59.962B | 27.06 |
| Baxter (BAX) | United States | $47.563B | 28.84 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $33.669B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $32.914B | 20.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $31.999B | 0.00 |
| Coloplast (CLPBY) | Denmark | $30.931B | 47.73 |
| Terumo (TRUMY) | Japan | $26.401B | 32.95 |
| ResMed (RMD) | United States | $25.542B | 44.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $21.089B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $18.226B | 0.00 |
| Insulet (PODD) | United States | $13.333B | 634.32 |
| Bio-Rad Laboratories (BIO) | United States | $12.243B | 57.20 |
| Perrigo (PRGO) | Ireland | $8.058B | 15.02 |
| William Demant Holdings (WILYY) | Denmark | $7.896B | 0.00 |
| Canopy Growth (CGC) | Canada | $7.606B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $7.537B | 38.94 |
| Hill-Rom Holdings (HRC) | United States | $7.276B | 20.93 |
| DiaSorin S.p.A (DSRLF) | Italy | $7.161B | 0.00 |
| Haemonetics (HAE) | United States | $6.058B | 37.29 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $5.020B | 0.00 |
| Envista Holdings (NVST) | United States | $4.488B | 0.00 |
| ICU Medical (ICUI) | United States | $4.469B | 29.13 |
| NuVasive (NUVA) | United States | $4.132B | 32.54 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.908B | 0.00 |
| Neogen (NEOG) | United States | $3.835B | 63.82 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $3.660B | 0.00 |
| Quidel (QDEL) | United States | $3.444B | 30.24 |
| Agios Pharmaceuticals (AGIO) | United States | $3.123B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.810B | 63.43 |
| Aurora Cannabis (ACB) | Canada | $1.999B | 0.00 |
| AtriCure (ATRC) | United States | $1.668B | 0.00 |
| TG Therapeutics (TGTX) | United States | $1.592B | 0.00 |
| Cardiovascular Systems (CSII) | United States | $1.556B | 0.00 |
| InMode (INMD) | Israel | $1.249B | 0.00 |
| NanoString Technologies (NSTG) | United States | $1.207B | 0.00 |
| Aphria (APHA) | $1.129B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.055B | 20.86 |
| VAREX IMAGING (VREX) | United States | $0.998B | 20.74 |
| PetIQ (PETQ) | United States | $0.983B | 23.99 |
| Cerus (CERS) | United States | $0.828B | 0.00 |
| Quanterix (QTRX) | United States | $0.805B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.723B | 27.68 |
| Omeros (OMER) | United States | $0.669B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.649B | 16.21 |
| LeMaitre Vascular (LMAT) | United States | $0.613B | 34.83 |
| MacroGenics (MGNX) | United States | $0.531B | 0.00 |
| Surmodics (SRDX) | United States | $0.513B | 58.99 |
| OraSure Technologies (OSUR) | United States | $0.439B | 54.77 |
| Organigram Holdings (OGI) | Canada | $0.433B | 0.00 |
| Owens & Minor (OMI) | United States | $0.423B | 15.65 |
| HEXO (HEXO) | $0.409B | 0.00 | |
| Utah Medical Products (UTMD) | United States | $0.356B | 25.29 |
| Meridian Bioscience (VIVO) | United States | $0.348B | 14.02 |
| Zynex (ZYXI) | United States | $0.344B | 38.89 |
| BioLife Solutions (BLFS) | United States | $0.334B | 136.00 |
| Repro-Med Systems (KRMD) | United States | $0.280B | 0.00 |
| Bovie Medical (APYX) | United States | $0.260B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.233B | 1175.00 |
| Viemed Healthcare (VMD) | United States | $0.217B | 22.92 |
| Vapotherm (VAPO) | United States | $0.212B | 0.00 |
| United Health Products (UEEC) | United States | $0.192B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.189B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.189B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.176B | 0.00 |
| Neptune Wellness Solutions (NEPT) | Canada | $0.159B | 0.00 |
| Green Organic Dutchman Holdings (TGODF) | Canada | $0.132B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.48 |
| Chimerix (CMRX) | United States | $0.106B | 0.00 |
| Surface Oncology (SURF) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MRI Interventions (CLPT) | United States | $0.088B | 0.00 |
| United-Guardian (UG) | United States | $0.080B | 20.35 |
| MTech Acquisition (KERN) | United States | $0.076B | 0.00 |
| Nephros (NEPH) | United States | $0.072B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.069B | 0.00 |
| FSD PHARMA INC (HUGE) | Canada | $0.045B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| NF Energy Saving (BIMI) | China | $0.031B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.024B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.021B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.014B | 0.00 |
| Senestech (SNES) | United States | $0.007B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.006B | 0.00 |
| Myomo (MYO) | United States | $0.004B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.004B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.002B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.002B | 0.00 |
